| Name | Title | Contact Details |
|---|
Rubber Stamps and More is a Davis, CA-based company in the Business Services sector.
Hudson Regional Hospital (HRH) is a private, for-profit acute care hospital located in Secaucus, New Jersey. Established in 1976 and formerly known as Riverside Hospital and Meadowlands Hospital Medical Center, HRH was renamed after its acquisition by Yan Moshe in 2018. The hospital is dedicated to providing comprehensive medical care to Northern New Jersey, emphasizing advanced technologies and facility enhancements. HRH offers a variety of medical services, including robotic surgery, emergency services, radiology and imaging, and labor and delivery. The Institute for Robotic Surgery at HRH is recognized as a Center of Excellence, utilizing advanced technologies like the da Vinci Xi Robotic Surgical System and Mazor Robotics for minimally invasive procedures. The hospital also features modernized facilities and patient concierge services to enhance the overall patient experience. Accredited by DNV-GL, HRH is committed to high-quality healthcare and is affiliated with nearly 800 skilled physicians, serving the community of Hudson County and surrounding areas.
Bellagio, A Wood Tank Co is a Healdsburg, CA-based company in the Business Services sector.
Pinetree Capital is a Pompano Beach, FL-based company in the Business Services sector.
CEPI – Coalition for Epidemic Preaparedness Innovations - is a new broad international coalition set up to fund development of vaccines against emerging infectious diseases with epidemic potential, where there are few market incentives. The epidemics like Ebola and SARS we have seen over the past years, have demonstrated the need for vaccines. Development of a vaccine takes many years, and it is too late to start when the outbreak has started. By having vaccines on the shelf ready for phase III early in an outbreak, we can demonstrate the vaccine efficacy and stop the outbreak while it is small. CEPI has already launched two calls for proposals; one for development of vaccines against MERS, Lassa and Nipah and one for the development of rapid response vaccine technology to enable development of vaccines against new and unknown diseases. CEPI was launched in January 2017 and now has funding totalling $620 million from soverign investors and philantropic institutions. CEPI`s investors are: The Governments of Australia, Belgium, Canada, Japan and Norway, as well as the Wellcome Trust and the Bill&Melinda Gates Foundation. In addition the European Commission will co fund activities with €250 million.